Cohance Lifesciences, Divi’s Laboratories, and SAI Life Sciences rallied after Jefferies initiated coverage with ‘Buy’ ratings, citing strong growth prospects in India’s CRDMO sector. The brokerage sees a high-teen revenue CAGR, led by China+1 diversification, pipeline visibility, and demand for diabetes and weight-loss therapies.
10+ MFs added these 8 stocks in February; 3 turned multibaggers, up to 140% in FY26
Over 10 mutual funds increased exposure to stocks like Multi Commodity Exchange of India, GE Vernova T&D India and National Aluminium Company in February, with